|
Volumn 10, Issue 10, 2011, Pages 1179-1185
|
Efficacy of a novel rosacea treatment system: An investigator-blind, randomized, parallel-group study
a
KGL Inc
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALOE BARBADENSIS EXTRACT;
ANTIINFLAMMATORY AGENT;
DERMATOLOGICAL AGENT;
METRONIDAZOLE;
SKIN CLEANSER;
SKIN MOISTURIZER;
SUNSCREEN;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DRY SKIN;
ERYTHEMA;
FEMALE;
HUMAN;
MORNING DOSAGE;
PATIENT SATISFACTION;
RANDOMIZED CONTROLLED TRIAL;
ROSACEA;
SINGLE BLIND PROCEDURE;
SKIN BURNING SENSATION;
SKIN CARE;
TOPICAL TREATMENT;
TREATMENT DURATION;
ADMINISTRATION, CUTANEOUS;
DERMATOLOGIC AGENTS;
ERYTHEMA;
FEMALE;
GELS;
HUMANS;
METRONIDAZOLE;
MIDDLE AGED;
ROSACEA;
SINGLE-BLIND METHOD;
SUN PROTECTION FACTOR;
SUNSCREENING AGENTS;
TREATMENT OUTCOME;
|
EID: 80054756740
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (7)
|